Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2018 · 10-Q
Revenue$2.94M$2.94M+81.2% vs Q2 2017 Net Income-$461.97K-$461.97KN/M vs Q2 2017 EPS Diluted-$0.00-$0.00N/M vs Q2 2017 Gross Profit$2,023,968+75.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,060,658N/M Free Cash Flowderived-$3,308,069N/M Margins · derivedGross margin68.9%−2.1 pt vs Q2 2017
Operating margin15.0%−22.1 pt vs Q2 2017
Net margin-15.7%−49.5 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end